# Biomarkers in Autosomal Dominant Cerebellar Ataxia

> **NCT01470729** · — · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 102 (actual)

## Conditions studied

- Spinocerebellar Ataxia Type 1
- Spinocerebellar Ataxia Type 2
- Spinocerebellar Ataxia, Autosomal Recessive 3
- Episodic Ataxia, Type 7

## Interventions

- **OTHER:** metabolic and imaging biomarkers in SCA1,2,3 and 7 patients

## Key facts

- **NCT ID:** NCT01470729
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2019-09-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01470729

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01470729, "Biomarkers in Autosomal Dominant Cerebellar Ataxia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01470729. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*